Scientists argue the criteria we use for diagnosing autism may need revision...
Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 disease...
Projects include important research on Parkinson鈥檚, glioblastoma and dementia 聽
YCharOS antibody characterization platform addresses the 鈥渞eproducibility crisis鈥� in research...
Free, online training program strengthens training and brings specialized care to communities across Quebec...
Academic and industry scientists collaborate on a new method to characterize research antibodies
Mapping immune cell diversity reveals dexamethasone鈥檚 impact on brain cancer immunotherapy...
$400,000 will fuel public-private collaboration to discover new disease biomarkers...
RSS